Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.68 - $0.91 $2,156 - $2,885
3,171 Added 0.27%
1,160,016 $962,000
Q1 2023

May 12, 2023

SELL
$0.5 - $0.72 $233,524 - $336,274
-467,048 Reduced 28.76%
1,156,845 $809,000
Q4 2022

Feb 10, 2023

BUY
$0.4 - $0.55 $579,212 - $796,417
1,448,031 Added 823.39%
1,623,893 $828,000
Q3 2022

Nov 14, 2022

SELL
$0.69 - $1.33 $8,402 - $16,196
-12,178 Reduced 6.48%
175,862 $112,000
Q2 2022

Aug 12, 2022

SELL
$0.92 - $2.25 $22,530 - $55,102
-24,490 Reduced 11.52%
188,040 $193,000
Q1 2022

May 16, 2022

BUY
$1.72 - $5.23 $35,440 - $107,764
20,605 Added 10.74%
212,530 $399,000
Q4 2021

Feb 08, 2022

BUY
$4.65 - $7.75 $18,446 - $30,744
3,967 Added 2.11%
191,925 $925,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $9.66 $22,651 - $36,167
3,744 Added 2.03%
187,958 $1.36 Million
Q2 2021

Sep 13, 2021

BUY
$9.23 - $13.12 $1.7 Million - $2.42 Million
184,214 New
184,214 $1.7 Million

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0

About Neoleukin Therapeutics, Inc.


  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.